SonALAsense
Phase 1/2SonALAsense is the first company to advance Sonodynamic Therapy into clinical trials.
Founded
2016
Focus
OncologyDrug Delivery
About
SonALAsense is the first company to advance Sonodynamic Therapy into clinical trials.
Funding History
2Total raised: $15M
Series A$15MUndisclosedMar 15, 2021
GrantUndisclosedNational Cancer InstituteJun 15, 2020
Company Info
TypePrivate
Founded2016
LocationBirmingham, United States
StagePhase 1/2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile